EMBRY HOLDINGS (01388) is expected to have a shareholder's net loss of approximately HK$250 million to HK$260 million in 2025.

Embry Holdings (01388) announced that the Group is expected to incur a net loss attributable to company owners of approximately HK$250 million to HK$260 million for the year ending December 31, 2025, compared to a net loss of approximately HK$373 million in 2024. The expected decrease in net loss is mainly due to non-recurring, unrealized, and non-cash items in the Group's income statement. Based on this expectation: i. the Group will recognize impairment of properties, plants, and equipment of approximately HK$40 million in the 2025 fiscal year, compared to impairment of approximately HK$119 million in the 2024 fiscal year. Due to the Group's conservative and cautious approach in assessing impairments of properties, plants, and equipment and the significant impairments recognized in the 2024 fiscal year, the impairments of the Group's production bases in Shandong and Changzhou are expected to decrease; ii. considering market price changes of surrounding properties, the Group's investment properties in two regions in mainland China, namely Shanghai and Changzhou, and the investment property in Hong Kong are expected to decrease by approximately HK$40 million in fair value in the 2025 fiscal year, compared to a decrease of approximately HK$69 million in fair value in the 2024 fiscal year; iii. for the same reasons as (ii), the Group will recognize impairment related to other assets in Shenzhen, China of approximately HK$32 million in 2025 fiscal year, compared to an impairment of approximately HK$39 million in the 2024 fiscal year, which were acquired for relocation arrangements in 2017; iv. due to the appreciation of the renminbi in the 2025 fiscal year, the Group will recognize a net exchange gain of approximately HK$4 million in 2025 fiscal year, compared to a net exchange loss of approximately HK$6 million in the 2024 fiscal year.